- Home
- BMY vs BSX Comparison
BMY vs BSX Comparison
Compare BMY & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BSX
- Stock Information
- Founded
- BMY 1887
- BSX 1979
- Country
- BMY United States
- BSX United States
- Employees
- BMY N/A
- BSX N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BSX Medical/Dental Instruments
- Sector
- BMY Health Care
- BSX Health Care
- Exchange
- BMY Nasdaq
- BSX Nasdaq
- Market Cap
- BMY 115.2B
- BSX 129.7B
- IPO Year
- BMY N/A
- BSX 1992
- Fundamental
- Price
- BMY $56.30
- BSX $98.65
- Analyst Decision
- BMY Hold
- BSX Strong Buy
- Analyst Count
- BMY 15
- BSX 23
- Target Price
- BMY $56.29
- BSX $96.41
- AVG Volume (30 Days)
- BMY 10.8M
- BSX 5.3M
- Earning Date
- BMY 02-06-2025
- BSX 02-05-2025
- Dividend Yield
- BMY 4.41%
- BSX N/A
- EPS Growth
- BMY N/A
- BSX 47.19
- EPS
- BMY N/A
- BSX 1.21
- Revenue
- BMY $47,435,000,000.00
- BSX $15,911,000,000.00
- Revenue This Year
- BMY $7.22
- BSX $17.70
- Revenue Next Year
- BMY $0.24
- BSX $13.00
- P/E Ratio
- BMY N/A
- BSX $81.61
- Revenue Growth
- BMY 5.56
- BSX 15.66
- 52 Week Low
- BMY $39.35
- BSX $59.85
- 52 Week High
- BMY $61.08
- BSX $99.14
- Technical
- Relative Strength Index (RSI)
- BMY 47.26
- BSX 75.24
- Support Level
- BMY $55.08
- BSX $93.20
- Resistance Level
- BMY $56.74
- BSX $97.13
- Average True Range (ATR)
- BMY 0.99
- BSX 1.55
- MACD
- BMY -0.07
- BSX 0.73
- Stochastic Oscillator
- BMY 41.74
- BSX 95.26
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.